Post-RFA Early Detection of HCC by Gd-EOB-DTPA-MRI study
Not Applicable
- Conditions
- Hepatocellular carcinoma (HCC)
- Registration Number
- JPRN-UMIN000010887
- Lead Sponsor
- Osaka Liver Study Group for Diagnosis,Treatment and Prevention of Hepatocellular Carcinoma
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
1.Extrahepatic liver metastasis 2.History of any cancer other than HCC within 5 years 3.Contraindication for MRI 4.Hypersensitivity to contrast agents of MRI or CT 5.Cirrhosis of Child-Pugh grade C 6.Hepatic encephalopathy of more than grade 2 7.Serum total bilirubin level of => 3 mg/dl 8.Patients judged as unsuitable for this study by the investiagators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Detection sensitivity of recurrence of hypervascular hepatocellular carcinoma after RFA between dynamic CT and GD-EOB-DTPA-enhanced MRI
- Secondary Outcome Measures
Name Time Method umber of tumors of recurrence of hepatocellular carcinoma after RFA between dynamic CT and GD-EOB-DTPA-enhanced MRI